Hernando Eye Institute

Brooksville, Florida 34615

0 studies enrolling now · 13 studies all time

What they study most

Blepharitis, Blepharoptosis, Dry Eye, Dry Eye Disease, Dry Eye Syndromes, Elevated Intraocular Pressure, Glaucoma, Glaucoma and Ocular Hypertension, Keratoconjunctivitis Sicca, Ocular Hypertension, Post-surgical Ocular Inflammation, Post-surgical Ocular Pain

Studies at this site

• A 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a Placebo — Completed
• A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease — Completed
• Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects — Completed
• A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study — Completed
• Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension — Completed
• Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) — Completed
• Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease — Completed
• Study of Safety of RVL-1201 in Treatment of Blepharoptosis — Completed
• Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis — Completed
• Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6 — Completed
• Ocular Hypotensive Efficacy of AR-102 — Completed
• A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP) — Completed
• The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) — Completed